Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Wal-Mart stocks EC

This article was originally published in The Tan Sheet

Executive Summary

Barr Labs' emergency contraceptive Plan B will be sold in Wal-Mart pharmacies nationwide effective March 20, the mass retailer announces March 3. Wal-Mart was required to sell the drug in Massachusetts following a ruling by the state's Pharmacy Board Feb. 14 (1"The Tan Sheet" Feb. 20, 2005, p. 5). The firm is also required to sell Plan B in Illinois, and states that "pressure to introduce similar mandates is building in Connecticut and New York." The likelihood of more states following suit and "the fact that this is an FDA-approved product" swayed the company, according to VP-Pharmacy Ron Chomiuk. "We feel it is difficult to justify being the country's only major pharmacy chain not selling" the drug, he stated. Wal-Mart will "maintain its conscientious objection policy," allowing pharmacists to refer consumers to other pharmacies if they object to filling the prescription...

You may also be interested in...

Wal-Mart Will Sell Plan B In Massachusetts; More States To Follow?

Wal-Mart has started stocking its pharmacies in Massachusetts with Barr Labs' Plan B emergency contraceptive following a Feb. 14 ruling by the state's Pharmacy Board

Coronavirus Update: Novartis Targets COVID-19 Cytokine Storm With Jakavi

Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients

As China Rushes Medical Supplies To World, Quality Issues Resurface

As China is poised to supply globally medical products to fight coronavirus, a battle to banish its image of poor product quality is on.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts